Links between Biology, Prognosis and Prediction of Response to Chemotherapy in Colorectal Cancer

Publisher： Karger

E-ISSN： 2296-5262|29|7|334-341

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.7, 2006-07, pp. : 334-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy

By  

Oncology, Vol. 82, Iss. 5, 2012-04 ,pp. : 261-268

Karger

Access to resources Recommend Favorite

Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 40, Iss. 1-2, 2017-01 ,pp. : 21-26

Karger

Access to resources Recommend Favorite

Costs of chemotherapy in the treatment of colorectal cancer

By Jansman F.   Postma M.  

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-06 ,pp. : 145-146

Springer Publishing Company

Access to resources Recommend Favorite

A Novel Scoring System Based on Fibrinogen and the Neutrophil-Lymphocyte Ratio as a Predictor of Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 90, Iss. 4, 2016-03 ,pp. : 186-192

Karger

Access to resources Recommend Favorite

High infiltration of tumor‐associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 6, 2015-05 ,pp. : 752-759

John Wiley & Sons Inc

Access to resources Recommend Favorite